Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
暂无分享,去创建一个
M. Suckow | F. Castellino | V. Ploplis | Steven A Buechler | Héctor Guillén-Ahlers | Steven A. Buechler
[1] K. Sugano,et al. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis , 2006, Journal of Gastroenterology.
[2] R. Gambari,et al. cDNA‐array profiling of melanomas and paired melanocyte cultures , 2006, Journal of cellular physiology.
[3] Hiroyuki Yamamoto,et al. Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis , 2006, Experimental biology and medicine.
[4] K. Druey,et al. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.
[5] M. Suckow,et al. Cathepsin E Is a Specific Marker of Dysplasia in APCMin/+ Mouse Intestine , 2005, Tumor Biology.
[6] C. McCaig,et al. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. , 2005, Cancer research.
[7] A. Puisieux,et al. Genome-wide analysis of gene expression in neuroblastomas detected by mass screening. , 2005, Cancer letters.
[8] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[9] C. Rhee,et al. Sulindac and its metabolites inhibit invasion of glioblastoma cells via down‐regulation of Akt/PKB and MMP‐2 , 2005, Journal of cellular biochemistry.
[10] C. Luparello,et al. Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells , 2005, Journal of cellular physiology.
[11] B. Pittman,et al. Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model , 2004, Clinical Cancer Research.
[12] K. Brierley,et al. A Clinician's Guide to Hereditary Colon Cancer , 2004, Cancer journal.
[13] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[14] Y. Mitani,et al. Gene Expression Profile of Gastric Carcinoma , 2004, Cancer Research.
[15] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[16] F. Castellino,et al. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. , 2003, Physiological genomics.
[17] Yusuke Nakamura,et al. Expression profile analysis of colon cancer cells in response to sulindac or aspirin. , 2002, Biochemical and biophysical research communications.
[18] M. Monden,et al. [Future scope for gene therapy for liver metastasis of colon cancer]. , 2001, Nihon Geka Gakkai zasshi.
[19] Po-Huang Lee,et al. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. , 2001, Biochemical and biophysical research communications.
[20] P. Jänne,et al. Chemoprevention of colorectal cancer. , 2000, The New England journal of medicine.
[21] B. Odermatt,et al. Loss of type VI collagen in experimental and most spontaneous human fibrosarcomas , 2000, International journal of cancer.
[22] E. Sahin,et al. Soluble Collagen VI Drives Serum-starved Fibroblasts through S Phase and Prevents Apoptosis via Down-regulation of Bax* , 1999, The Journal of Biological Chemistry.
[23] B. Rigas,et al. Sulindac sulfide alters the expression of cyclin proteins in HT‐29 colon adenocarcinoma cells , 1998, International journal of cancer.
[24] M. Mcentee,et al. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. , 1997, Cancer research.
[25] B. Rigas,et al. Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67. , 1997, Cancer letters.
[26] B. Hogan,et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[28] B. Rigas,et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. , 1996, Biochemical pharmacology.
[29] B. Rigas,et al. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.
[30] R. Sampliner,et al. NSAID effect on sporadic colon polyps. , 1993, The American journal of gastroenterology.
[31] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[32] K. Kinzler,et al. Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.
[33] K. Kinzler,et al. Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.
[34] R. Timpl,et al. Binding of the proteoglycan decorin to collagen type VI. , 1992, The Journal of biological chemistry.
[35] Friend Wg. Sulindac suppression of colorectal polyps in Gardner's syndrome. , 1990 .
[36] H. Pitot,et al. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.
[37] E. Engvall,et al. Type VI Collagen: Studies on Its Localization, Structure, and Biosynthetic Form with Monoclonal Antibodies , 1984, The Journal of biological chemistry.
[38] W. Waddell,et al. Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.
[39] M. Hollingsworth,et al. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice , 2004, Clinical & Experimental Metastasis.
[40] S. Ritland,et al. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. , 1999, Carcinogenesis.
[41] J. Faivre,et al. Chemoprevention of colorectal cancer. , 1999, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[42] M. Bertagnolli,et al. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. , 1998, Carcinogenesis.
[43] I. Talbot,et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. , 1996, Cancer research.
[44] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[45] W. Friend. Sulindac suppression of colorectal polyps in Gardner's syndrome. , 1990, American family physician.
[46] R. Timpl. Type VI Collagen , 1987 .